J8670 HCPCS Level II code: Rolapitant, oral, 1 mg
J8670 is the HCPCS code for “Rolapitant, oral, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J8670Rolapitant, oral, 1 mg
Short description: Rolapitant, oral, 1mg
HCPCS · United States
Notes for J8670
As CMS prints them, with any note J8670 takes from the headings above it.
Note
- CMS processing note 0211: PUB 100-4, CH 17, SEC 80.4.
Medicare details
The indicators CMS publishes with J8670 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2017
Where J8670 sits
- 1J codesDrugs administered other than orally
- 2Active code J8670Rolapitant, oral, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J8670 mean?
J8670 is the HCPCS code for “Rolapitant, oral, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J8670?
CMS lists J8670’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J8670
All J codesJ8600Melphalan; oral, 2 mgJ8610Methotrexate; oral, 2.5 mgJ8611Methotrexate (jylamvo), oral, 2.5 mgJ8612Methotrexate (xatmep), oral, 2.5 mgJ8650Nabilone, oral, 1 mgJ8655Netupitant 300 mg and palonosetron 0.5 mg, oralJ8700Temozolomide, oral, 5 mgJ8705Topotecan, oral, 0.25 mgJ8999Prescription drug, oral, chemotherapeutic, nosJ9000Injection, doxorubicin hydrochloride, 10 mgJ9003Leuprolide injectable (camcevi etm), 1 mgJ9010Injection, alemtuzumab, 10 mg